ES437150A1 - Procedimiento para la produccion de derivados de xantina. - Google Patents

Procedimiento para la produccion de derivados de xantina.

Info

Publication number
ES437150A1
ES437150A1 ES437150A ES437150A ES437150A1 ES 437150 A1 ES437150 A1 ES 437150A1 ES 437150 A ES437150 A ES 437150A ES 437150 A ES437150 A ES 437150A ES 437150 A1 ES437150 A1 ES 437150A1
Authority
ES
Spain
Prior art keywords
radicals
alkylxanthines
hydroxyhexyl
formula
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437150A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES437150A1 publication Critical patent/ES437150A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES437150A 1973-07-11 1975-04-29 Procedimiento para la produccion de derivados de xantina. Expired ES437150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2335170A DE2335170C2 (de) 1973-07-11 1973-07-11 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES437150A1 true ES437150A1 (es) 1977-01-16

Family

ID=5886518

Family Applications (3)

Application Number Title Priority Date Filing Date
ES417828A Expired ES417828A1 (es) 1973-07-11 1973-08-11 Procedimiento para la produccion de derivados de xantina.
ES437151A Expired ES437151A1 (es) 1973-07-11 1975-04-29 Procedimiento para la produccion de derivados de xantina.
ES437150A Expired ES437150A1 (es) 1973-07-11 1975-04-29 Procedimiento para la produccion de derivados de xantina.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES417828A Expired ES417828A1 (es) 1973-07-11 1973-08-11 Procedimiento para la produccion de derivados de xantina.
ES437151A Expired ES437151A1 (es) 1973-07-11 1975-04-29 Procedimiento para la produccion de derivados de xantina.

Country Status (17)

Country Link
US (1) US4108995A (es)
AR (4) AR199915A1 (es)
AT (1) AT333300B (es)
BE (1) BE816869R (es)
CA (1) CA1062709A (es)
CH (4) CH587853A5 (es)
DE (1) DE2335170C2 (es)
DK (1) DK147004C (es)
ES (3) ES417828A1 (es)
FI (1) FI61703C (es)
FR (1) FR2236501B2 (es)
GB (1) GB1480836A (es)
IE (1) IE41822B1 (es)
NL (1) NL168703C (es)
NO (2) NO140596C (es)
SE (1) SE415354B (es)
ZA (1) ZA744373B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207321A (en) * 1977-04-02 1980-06-10 Hoechst Aktiengesellschaft Pharmaceutical compositions containing xanthines
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
DE3942871A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
DE926788C (de) * 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
US4108995A (en) 1978-08-22
FI61703C (fi) 1982-09-10
ATA684573A (de) 1976-03-15
AR202663A1 (es) 1975-06-30
NL168703C (nl) 1982-05-17
CH587853A5 (es) 1977-05-13
GB1480836A (en) 1977-07-27
DK147004C (da) 1984-08-20
FI61703B (fi) 1982-05-31
NL7311123A (nl) 1975-01-14
FI206574A (es) 1975-01-12
DE2335170A1 (de) 1975-01-30
CH587850A5 (es) 1977-05-13
AU7101974A (en) 1976-01-15
DK147004B (da) 1984-03-12
AR202662A1 (es) 1975-06-30
DK438373A (es) 1975-03-03
AR200626A1 (es) 1974-11-22
BE816869R (fr) 1974-12-27
ZA744373B (en) 1975-07-30
ES417828A1 (es) 1976-03-16
FR2236501A2 (es) 1975-02-07
AR199915A1 (es) 1974-10-08
IE41822L (en) 1975-01-11
NO742464L (es) 1975-02-10
CA1062709A (en) 1979-09-18
SE415354B (sv) 1980-09-29
NO790627L (no) 1975-01-14
SE7310986L (sv) 1975-01-13
NO143064C (no) 1980-12-10
CH587851A5 (es) 1977-05-13
NO143064B (no) 1980-09-01
NO140596B (no) 1979-06-25
IE41822B1 (en) 1980-04-09
NO140596C (no) 1979-10-03
CH587852A5 (es) 1977-05-13
NL168703B (nl) 1981-12-16
ES437151A1 (es) 1977-01-16
DE2335170C2 (de) 1989-07-20
AT333300B (de) 1976-11-10
FR2236501B2 (es) 1979-08-10

Similar Documents

Publication Publication Date Title
ES394421A1 (es) Procedimiento para la produccion de derivados de fenil-imi-dazolilalcalino.
ES394370A1 (es) Procedimiento para la preparacion de derivados de la inso-indolina.
ES437150A1 (es) Procedimiento para la produccion de derivados de xantina.
ES384491A1 (es) Procedimiento para la obtencion de derivados de acetil- guanidina.
ES421068A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES389360A1 (es) Procedimiento para la preparacion de acidos ariloxi- o bienariltioalcanicos.
ES423058A1 (es) Procedimiento de preparacion de nuevos deivados de la i- soindolina.
ES423233A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas-(2) sustituidas.
ES389473A1 (es) Un procedimiento de preparacion de derivados de aminocarbo-nil-3 oxazolidinona-2.
ES332749A1 (es) Procedimiento para la produccion de derivados de la sulfo- nil urea.
ES435351A1 (es) Procedimiento para preparar 1-(3-fenil-propil)-4-furoilpi- perazinas.
ES327297A1 (es) Procedimiento para la obtencion de compuestos derivados de la quinazolina.
ES392848A1 (es) Un procedimiento para la preparacion de nuevos derivados de indenopirrol.
ES388464A1 (es) Procedimiento para la preparacion de fenoxietilaminas sus- tituidas.
ES440135A1 (es) Procedimiento para producir s-inosilcisteina.
ES401342A1 (es) Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales.
ES428624A1 (es) Procedimiento para la preparacion de derivados de la pirimi-dina.
ES413742A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
ES360859A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazepina.
ES407798A3 (es) Procedimiento para la preparacion de nuevos derivados de tiocromano.
ES294197A1 (es) Procedimiento para la preparación de nuevos derivados azepínicos
GB1021530A (en) Derivatives of 2-oxo-2h-1,4-benzoxazine
ES402181A1 (es) Procedimiento para la obtencion de derivados de 5 - nitro- furilo.
ES424470A1 (es) Un procedimiento para la preparacion de compuestos hetero- ciclicos del tipo de los pinanopirazoles.
ES382623A1 (es) Procedimiento para la preparacion de nuevos derivados de i-midazolidinona.